Literature DB >> 14705812

CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers.

G W Lynch1, E K Slaytor, F D Elliott, A Saurajen, S G Turville, A J Sloane, P U Cameron, A L Cunningham, G M Halliday.   

Abstract

Langerhans' cells (LC) of skin are CD4 expressing, dendritic, antigen-presenting cells, that are essential for activation of primary immune responses and are productively infected by HIV. We have shown previously that lymphocytes and monocytes express CD4 both as monomers and covalently linked homodimers. In those cells the 55-kDa monomer structure predominates. LC in un-fractionated human epidermal cell (EC) suspension also expresses both forms of CD4, but in EC the dimer form is predominant. Because isolation of LC into single cell suspension by trypsin, as is routinely used for LC isolation, degrades CD4, a systematic study for an alternate procedure for LC isolation was performed. Thus it was found that collagenase blend F treatment can efficiently release LC into suspension, under conditions of only minimal degradation of control soluble recombinant CD4 or CEM-T4 or THP-1 cell CD4, or importantly of LC surface CD4. SDS-PAGE immunoblotting of purified LC extracted from EC by collagenase confirmed CD4 structure as predominantly 110-kDa dimers, with only minimal 55-kDa monomers. The suitability of LC prepared thus for functional studies was demonstrated with binding of functional ligand HIV gp120. It remains to be determined, however, why tissue embedded LC express mainly CD4 dimers, but single-celled blood lymphocytes and monocytes mainly monomers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14705812     DOI: 10.1034/j.1600-0625.2003.00078.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  13 in total

1.  Reduced monomeric CD4 is the preferred receptor for HIV.

Authors:  Lisa J Matthias; Iman Azimi; Catherine A Tabrett; Philip J Hogg
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

3.  Differential compartmentalization of HIV-targeting immune cells in inner and outer foreskin tissue.

Authors:  Aiping Liu; Yu Yang; Lu Liu; Zhefeng Meng; Liangzhu Li; Chao Qiu; Jianqing Xu; Xiaoyan Zhang
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 4.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

5.  Single-molecule analysis of human immunodeficiency virus type 1 gp120-receptor interactions in living cells.

Authors:  Melissa I Chang; Porntula Panorchan; Terrence M Dobrowsky; Yiider Tseng; Denis Wirtz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Revisiting the Experimental Methods for Human Skin T-Cell Analysis.

Authors:  Takuya Sato; Youichi Ogawa; Aoha Ishikawa; Yuka Nagasaka; Manao Kinoshita; Ichiro Shiokawa; Shinji Shimada; Akira Momosawa; Tatsuyoshi Kawamura
Journal:  JID Innov       Date:  2022-03-23

7.  The in vivo expression of dipeptidyl peptidases 8 and 9.

Authors:  Denise M T Yu; Katerina Ajami; Margaret G Gall; Joohong Park; C Soon Lee; Kathryn A Evans; Eileen A McLaughlin; Melissa R Pitman; Catherine A Abbott; Geoffrey W McCaughan; Mark D Gorrell
Journal:  J Histochem Cytochem       Date:  2009-07-06       Impact factor: 2.479

8.  Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation.

Authors:  Kerrie J Sandgren; Anna Smed-Sörensen; Mattias N Forsell; Martina Soldemo; William C Adams; Frank Liang; Leif Perbeck; Richard A Koup; Richard T Wyatt; Gunilla B Karlsson Hedestam; Karin Loré
Journal:  J Immunol       Date:  2013-05-31       Impact factor: 5.422

9.  DMBA/TPA treatment is necessary for BCC formation from patched deficient epidermal cells in Ptch(flox/flox)CD4Cre(+/-) mice.

Authors:  Anja Uhmann; Ina Heß; Anke Frommhold; Simone König; Sebastian Zabel; Frauke Nitzki; Kai Dittmann; Fred Lühder; Hans Christiansen; Julia Reifenberger; Walter Schulz-Schaeffer; Heidi Hahn
Journal:  J Invest Dermatol       Date:  2014-03-24       Impact factor: 8.551

10.  Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry.

Authors:  Rachel Bourgeois; Johanne Mercier; Isabelle Paquette-Brooks; Eric A Cohen
Journal:  Retrovirology       Date:  2006-06-08       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.